1999Anesthesia & AnalgesiaRequires access

Meperidine in Forearm Intravenous Regional Anesthesia?

Scott S. Reuben, Robert Steinberg

Open publisher page 0 citations

Abstract

We appreciate the comment by Drs. Coleman and Chan suggesting that a smaller dose of meperidine (15 mg) may be beneficial when used as a component of IV regional anesthesia (IVRA) lidocaine 0.5% using a forearm tourniquet. Although prolonged analgesia with meperidine doses ≥30 mg can be achieved, we believe the peak plasma meperidine concentrations that result after tourniquet release were large enough to cause the centrally mediated opioid side effects we observed (1). The incidence of these side effects was less frequent with meperidine doses ≤20 mg and was found to be statistically similar to the control group. Perhaps 15 mg of meperidine in IVRA lidocaine using a forearm tourniquet provides effective postoperative analgesia with a lower incidence of side effects. IVRA with a forearm tourniquet provides safe and effective analgesia using smaller doses of lidocaine (2–4). In addition, a forearm tourniquet may be tolerated for a longer (5) or at least equal (6) period of time as an upper arm tourniquet. However, the use of a forearm tourniquet remains controversial. Sanders (7) states that “tourniquets should never be placed distal to the elbow” because of a greater risk of nerve injury and breakthrough bleeding. A forearm tourniquet may not adequately compress the anterior and posterior interosseous arteries located between the radius and ulna, leading to a greater incidence of blood leakage (8). The use of a forearm tourniquet is not recommended for hypertensive patients because of an increased incidence of venous congestion and inadequate analgesia observed with this technique (2). Furthermore, ulnar neuropathy has been reported after the use of a forearm tourniquet (9), perhaps occurring more often than with an upper arm tourniquet. The ulnar nerve can be transfixed between the tourniquet and the ulna, and if the elbow is inadvertently flexed during surgery, a traction neuritis can develop. Although smaller doses of meperidine and lidocaine may be used during IVRA with a forearm tourniquet, this technique should be used with caution. Moreover, the analgesic effects of meperidine in these circumstances have never been investigated. Scott S. Reuben MD Robert S. Steinberg MD, PhD

About this research paper

What this paper is about

We appreciate the comment by Drs. Coleman and Chan suggesting that a smaller dose of meperidine (15 mg) may be beneficial when used as a component of IV regional anesthesia (IVRA) lidocaine 0.5% using a forearm tourniquet. Although prolonged analgesia with meperidine doses ≥30 mg can be achieved, we believe the peak plasma meperidine concentrations that result after tourniquet release were large enough to cause the centrally mediated opioid side effects we observed (1). The incidence of these side effects was less frequent with meperidine doses ≤20 mg and was found to be statistically similar to the control group. Perhaps 15 mg of meperidine in IVRA lidocaine using a forearm tourniquet provides effective postoperative analgesia with a lower incidence of side effects. IVRA with a forearm tourniquet provides safe and effective analgesia using smaller doses of lidocaine (2–4). In addition, a forearm tourniquet may be tolerated for a longer (5) or at least equal (6) period of time as an upper arm tourniquet. However, the use of a forearm tourniquet remains controversial. Sanders (7) states that “tourniquets should never be placed distal to the elbow” because of a greater risk of nerve injury and breakthrough bleeding. A forearm tourniquet may not adequately compress the anterior and posterior interosseous arteries located between the radius and ulna, leading to a greater incidence of blood leakage (8). The use of a forearm tourniquet is not recommended for hypertensive patients because of an increased incidence of venous congestion and inadequate analgesia observed with this technique (2). Furthermore, ulnar neuropathy has been reported after the use of a forearm tourniquet (9), perhaps occurring more often than with an upper arm tourniquet. The ulnar nerve can be transfixed between the tourniquet and the ulna, and if the elbow is inadvertently flexed during surgery, a traction neuritis can develop. Although smaller doses of meperidine and lidocaine may be used during IVRA with a forearm tourniquet, this technique should be used with caution. Moreover, the analgesic effects of meperidine in these circumstances have never been investigated. Scott S. Reuben MD Robert S. Steinberg MD, PhD

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We appreciate the comment by Drs. Coleman and Chan suggesting that a smaller dose of meperidine (15 mg) may be beneficial when used as a component of IV regional anesthesia (IVRA) lidocaine 0.5% using a forearm tourniquet. Although prolonged analgesia with meperidine doses ≥30 mg can be achieved, we believe the peak plasma meperidine concentrations that result after tourniquet release were large enough to cause the centrally mediated opioid side effects we observed (1). The incidence of these side effects was less frequent with meperidine doses ≤20 mg and was found to be statistically similar to the control group. Perhaps 15 mg of meperidine in IVRA lidocaine using a forearm tourniquet provides effective postoperative analgesia with a lower incidence of side effects. IVRA with a forearm tourniquet provides safe and effective analgesia using smaller doses of lidocaine (2–4). In addition, a forearm tourniquet may be tolerated for a longer (5) or at least equal (6) period of time as an upper arm tourniquet. However, the use of a forearm tourniquet remains controversial. Sanders (7) states that “tourniquets should never be placed distal to the elbow” because of a greater risk of nerve injury and breakthrough bleeding. A forearm tourniquet may not adequately compress the anterior and posterior interosseous arteries located between the radius and ulna, leading to a greater incidence of blood leakage (8). The use of a forearm tourniquet is not recommended for hypertensive patients because of an increased incidence of venous congestion and inadequate analgesia observed with this technique (2). Furthermore, ulnar neuropathy has been reported after the use of a forearm tourniquet (9), perhaps occurring more often than with an upper arm tourniquet. The ulnar nerve can be transfixed between the tourniquet and the ulna, and if the elbow is inadvertently flexed during surgery, a traction neuritis can develop. Although smaller doses of meperidine and lidocaine may be used during IVRA with a forearm tourniquet, this technique should be used with caution. Moreover, the analgesic effects of meperidine in these circumstances have never been investigated. Scott S. Reuben MD Robert S. Steinberg MD, PhD

Key concepts: Tourniquet, Intravenous regional anesthesia, Medicine, Forearm, Anesthesia, Lidocaine, Elbow, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source